Another limitation is the relatively small size of our PPMS group (100 total patients), which may account for the lack of statistical significance with respect to STK11-SNP being a predictor for MS, or its association with the HLA-DRB1*1501 allele. Here, HLA-DRB1 is linked to myeloid sarcoma.